Transient Potential Receptor Melastatin-2 (TRPM2) Does Not Influence Murine MLL-AF9 Driven AML Leukemogenesis or in Vitro Response to Chemotherapy

Por Haladyna, Jessica N., Pastuer, Taylor, Riedel, Simone S, Perraud, Anne-Laure, Bernt, Kathrin M
Publicado no Exp Hematol (2016)

Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic Leukemia

Por Danis, Etienne, Yamauchi, Taylor, Echanique, Kristen, Zhang, Xi, Haladyna, Jessica N., Riedel, Simone S., Zhu, Nan, Xie, Huafeng, Orkin, Stuart H., Armstrong, Scott A., Bernt, Kathrin M., Neff, Tobias
Publicado no Cell Rep (2016)

Inhibition of the oncogenic fusion protein EWS-FLI1 causes G(2)-M cell cycle arrest and enhanced vincristine sensitivity in Ewing’s sarcoma

Por Zöllner, Stefan K., Selvanathan, Saravana P., Graham, Garrett T., Commins, Ryan M. T., Hong, Sung Hyeok, Moseley, Eric, Parks, Sydney, Haladyna, Jessica N., Erkizan, Hayriye V., Dirksen, Uta, Hogarty, Michael D., Üren, Aykut, Toretsky, Jeffrey A.
Publicado no Sci Signal (2017)

MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia

Por Riedel, Simone S., Haladyna, Jessica N., Bezzant, Matthew, Stevens, Brett, Pollyea, Daniel A., Sinha, Amit U., Armstrong, Scott A., Wei, Qi, Pollock, Roy M., Daigle, Scott R., Jordan, Craig T., Ernst, Patricia, Neff, Tobias, Bernt, Kathrin M.
Publicado no J Clin Invest (2016)